Next 10 |
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Surmodics, Inc. (NASDAQ:SRDX)'s sale ...
2024-06-10 08:08:34 ET More on Surmodics Surmodics jumps 18% on acquisition by GTCR Surmodics beats top-line and bottom-line estimates; updates FY24 outlook Seeking Alpha’s Quant Rating on Surmodics Historical earnings data for Surmodics Read...
Access to Premier’s healthcare group purchasing organization (GPO) expected to expand national market reach for Surmodics endovascular thrombectomy solutions. Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announce...
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Stericycle, Inc. (NASDAQ:SRCL)'s sale...
A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 37.2% to $0.0494 on volume of 615,002,672 shares Innovative Eyewear Inc. (LUCY) rose 131.5% to $0.949 on volume of 566,381,896 shares Faraday Future Intelligent Electric Inc. (FFIE) fell...
2024-05-29 15:15:03 ET Lake Street analyst issues HOLD recommendation for SRDX on May 29, 2024 01:37PM ET. SRDX was trading at $42.07 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 1 - Hold recommendati...
2024-05-29 15:00:09 ET Brooks O'Neil from Lake Street issued a price target of $43.00 for SRDX on 2024-05-29 13:37:00. The adjusted price target was set to $43.00. At the time of the announcement, SRDX was trading at $42.07. The overall price target consensus is at $36.0...
MONSEY, N.Y., May 29, 2024 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the price of $43.00 per share in cash for which Surmodics, Inc. (Nasdaq: SRDX) (“Surmodics”) has agreed to be sold to GTCR, a leading private equity firm. The sale...
A look at the top 10 most actives in the United States ReShape Lifesciences Inc. (RSLS) rose 89.7% to $0.3942 on volume of 109,324,190 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 30.3% to $0.8151 on volume of 100,649,842 shares Innovative Eyewear Inc. (LUCY) rose 61.0% to ...
2024-05-29 07:31:31 ET SRDX stock price gained 18.4% More on Surmodics Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript Surmodics beats top-line and bottom-line estimates; updates FY24 outlook Needham sees BSX, CNMD, RMD beating Street, despite medtech...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Surmodics, Inc. (NASDAQ:SRDX)'s sale ...
Access to Premier’s healthcare group purchasing organization (GPO) expected to expand national market reach for Surmodics endovascular thrombectomy solutions. Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announce...
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Stericycle, Inc. (NASDAQ:SRCL)'s sale...